Roger Damle, MD
Clinical Cardiac Electrophysiology · Littleton, CONPI 1114944030
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 84 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 12 manufacturers reported payments, led by Impulse Dynamics (USA) Inc. at 31.4% of the total. Reporting peaked in 2019 at $1,188 and has fallen 54.6% since, to $540 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CO, where the typical reported total is $11,587.
Across 84 payments — averaging $48.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Impulse Dynamics (USA) Inc.$1K
- Abbott$1K
- Biosense Webster, Inc.$684
- Boston Scientific$607
- Inspire Medical Systems, Inc.$184
- Pfizer$163
- plus $158 from 6 others
Across 1 payment — averaging $165.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$165
What the payments were for
- Food & beverage$4,113100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Impulse Dynamics (USA) Inc. | 18 | $1,291 |
| Abbott | 28 | $1,027 |
| Biosense Webster, Inc. | 10 | $684 |
| Boston Scientific | 9 | $607 |
| Inspire Medical Systems, Inc. | 2 | $184 |
| Pfizer | 10 | $163 |
| Atricure, Inc. | 2 | $49 |
| Novo Nordisk | 1 | $34 |
| Novartis | 1 | $25 |
| Medtronic | 1 | $20 |
| E.r. Squibb & Sons, L.L.C. | 1 | $17 |
| Amgen | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- OPTIMIZER$433
- RHYTHMIA$256
- Carto 3$239
- Tendril Pacing Lead$134
- Inspire Upper Airway Stimulation System$129
- VISITAG SURPOINT External Processing Unit$118
- Agilis HisPro$108
- CartoUnivu$103
- Soundstar$103
How this compares
$4,113 in reported general payments places this provider in the 25th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
See all clinical cardiac electrophysiology providers in Colorado →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 802 | $1,080,061 |
| XareltoRivaroxaban | 203 | $284,372 |
| EntrestoSacubitril/Valsartan | 25 | $35,806 |
| Dofetilide | 109 | $17,112 |
| JardianceEmpagliflozin | 12 | $16,645 |
| Metoprolol Succinate | 572 | $9,620 |
| Flecainide Acetate | 85 | $4,632 |
| Rosuvastatin Calcium | 215 | $3,620 |
| Nebivolol Hcl | 29 | $2,821 |
| Amiodarone Hcl | 115 | $2,488 |
| Acebutolol Hcl | 31 | $2,377 |
| Atorvastatin Calcium | 260 | $2,269 |
| Losartan Potassium | 265 | $2,066 |
| Metoprolol Tartrate | 181 | $1,901 |
| Lisinopril | 163 | $1,478 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $163 | $1,080,061802 claims |
| NovartisEntresto | $25 | $35,80625 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 25th percentile of 66 clinical cardiac electrophysiology providers in Colorado.
Other clinical cardiac electrophysiology in Littleton
- Srikanth SundaramLittleton$493K
- Henry ZhengLittleton$58K
- William ChoeLittleton$20K
- Jamie JordanLittleton$3K
- Jehu MathewLittleton$2K
- Bradley MikaelianColorado Springs$364K
- Wendy TzouAurora$350K
- Christopher PorterfieldAurora$340K
- Lohit GargAurora$147K
- Ethan EllisFort Collins$144K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.